Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Glympse Bio, Inc. Raises $22M Series A Financing
Venture Capital

Glympse Bio, Inc. Raises $22M Series A Financing

by vcaonline.com posted 2months ago 24 views
CAMBRIDGE, Mass., October 9, 2018-- Glympse Bio, Inc. announced today that it has raised $22 million in Series A funding. The proceeds of this round will be devoted to conducting clinical trials for its novel platform which uses bioengineered activity sensors to noninvasively detect human diseases and to monitor drug response. Glympse Bio is a spin-out from the laboratory of Sangeeta Bhatia, M.D., Ph.D. at the Massachusetts Institute of Technology. The financing round was co-led by venture capital firms LS Polaris Innovation Fund and ARCH Ventures.

In this article